COMMUNIQUÉS West-GlobeNewswire

Aleafia Health Applauds Commitment to Private Retail Expansion in Ontario Budget
12/04/2019
Company has Equity Stakes and Supply Agreements With Three Major Retail Partners Budget Announced Major Expansion of Cannabis Retail Licences in Canada’s Largest Province TORONTO, April 12, 2019 (GLOBE NEWSWIRE) -- [...]
AroCell´s 2018 Annual Report published
12/04/2019
AroCell today announces that the Annual Report for 2018 is now available on the company’s website: www.arocell.com . The Annual report is available on the following link: arocell.com/årsredovisning-2018 The report is [...]
GN Audio upgrades financial guidance for 2019
12/04/2019
GN Audio has had a very strong start to 2019, with the following preliminary numbers for Q1 2019: Revenue: DKK 1,333 million Organic revenue growth: 36% EBITA reported: DKK 192 million EBITA margin reported: 14.4% [...]
Press release: Curetis’ Subsidiary Ares Genetics Introduces NGS Services for Pharma and Public Health Sector at Upcoming ECCMID 2019
12/04/2019
Strain-typing and AMR detection of clinical isolates based on ARESdb Set-up of own NGS service laboratory in Vienna, Austria Vienna, Austria, Holzgerlingen, Germany, and Amsterdam, The Netherlands, April 12, 2019, 08:00 [...]
DEINOVE invited to present at the 29th congress of the European Society of Clinical Microbiology and Infectious Diseases
12/04/2019
Georges GAUDRIAULT, Scientific Director of DEINOVE, will give a talk at the ECCMID, at the ‘Therapeutics pipeline corner’, on this coming Sunday, April 14 th , in Amsterdam. He will describe the progress of the DNV3837 [...]
Basilea reports isavuconazole (Cresemba®) and ceftobiprole (Zevtera®) presentations at European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
12/04/2019
Basel, Switzerland, April 12, 2019 – Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that a broad range of posters and presentations on the antifungal isavuconazole (Cresemba ® ) and the antibiotic ceftobiprole ( [...]
PhaseBio Announces Pricing of Public Offering of Common Stock
12/04/2019
MALVERN, Pa., and SAN DIEGO, April 11, 2019 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel [...]
Cooper Fitness Center Introduces Move.Laugh.Connect. Program
11/04/2019
Cooper Program For Total Well-being Extends Functional Years DALLAS, April 11, 2019 (GLOBE NEWSWIRE) -- Cooper Fitness Center announces a new program, Move.Laugh.Connect. (MLC) as a balanced program for total well-being [...]
Cerner and naviHealth Expand Relationship, Plan to Launch Offering for Bundled Payments for Care Improvement Advanced (BPCI Advanced)
11/04/2019
KANSAS CITY, Mo., April 11, 2019 (GLOBE NEWSWIRE) -- Health care providers that want to participate in Medicare’s Bundled Payments for Care Improvement Advanced program (BPCI Advanced) can soon look to Cerner , a global [...]
Alliqua BioMedical Declares Contingent Special Dividend of $1.05 per Share and Announces Record Date for the Contingent Special Dividend and the Spin-Off of Contract Manufacturing Business
11/04/2019
LANGHORNE, Pa., April 11, 2019 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq: ALQA) announced today that its Board of Directors has declared a special cash dividend of $1.05 for each share of common stock [...]
KemPharm Completes KP415 Pre-NDA Meeting with FDA
11/04/2019
KP415 NDA Filing Anticipated in Late Q2 or Early Q3 2019 Conference Call Scheduled for Today, Thursday, April 11, 2019 at 5:00 p.m. ET CELEBRATION, Fla., April 11, 2019 (GLOBE NEWSWIRE) -- KemPharm, Inc. (Nasdaq: KMPH [...]
UPDATE – Natus Medical to Hold 2019 First Quarter Financial Results Conference Call on April 25th
11/04/2019
PLEASANTON, Calif., April 11, 2019 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY), a leading provider of medical devices and services, today announced that the Company will release its 2019 first quarter [...]
VBI Vaccines Appoints Joanne Cordeiro to Board of Directors
11/04/2019
CAMBRIDGE, Mass., April 11, 2019 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (NASDAQ: VBIV) (“VBI”), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, [...]
Recro Pharma Announces Presentation of New Meta-Analysis for IV Meloxicam at the 44th Annual Regional Anesthesiology and Acute Pain Medicine Meeting
11/04/2019
New Meta-Analysis Data Suggests IV Meloxicam Produces Largest SPID, Greater Reduction in Opioid Use and Better Safety Profile Compared to Other Non-Opioid Medications for Moderate to Severe Pain Abstract Among the [...]
GW Pharmaceuticals and its U.S. Subsidiary Greenwich Biosciences Announce Appointment of Darren Cline as U.S. Chief Commercial Officer
11/04/2019
CARLSBAD, Calif., April 11, 2019 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), the world leader in the development and commercialization of cannabinoid prescription medicines, [...]
COPE Health Solutions Adds Population Health and Value-Based Payments Experts
11/04/2019
NEW YORK, April 11, 2019 (GLOBE NEWSWIRE) -- COPE Health Solutions has expanded its senior leadership team with the addition of Robert A. Minkin, FACHE, as Principal and Samuel Shutman as Senior Vice President. As [...]
LONG ISLAND PLASTIC SURGICAL GROUP RAISES $30,000 FOR RESURGE INTERNATIONAL
11/04/2019
The Funds Will Go Towards Continuing Dr. Vincent DiGregorio's Legacy of Providing Free Medical Training to Communities in Need Garden City, NY, April 11, 2019 (GLOBE NEWSWIRE) -- Long Island Plastic Surgical Group ( [...]
Aleafia Health Opens the Market
11/04/2019
TORONTO, April 11, 2019 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“ Aleafia Health ” or the “ Company ”) opened the market at the Toronto Stock Exchange (“TSX”) in recognition of the [...]
Tecan strengthens development and operations organizations
11/04/2019
Dr. Wael Yared appointed as CTO and Head Research & Development and a member of the Management Board Ulrich Kanter will continue to lead the Operations division with increased responsibilities and scope Männedorf, [...]

Pages